Abstract:Introduction: Curcumin, the active ingredient of turmeric, generates reactive oxygen species, increases p53 expression, inhibits NFⲕB signaling, and can induce apoptosis. Despite these potential anticancer effects, there has not yet been a systematic analysis of the effects of curcumin on a large panel of cancer cell lines. We hypothesized that curcumin has differential effects based on the specific cell line and its tissue of origin. This study assessed curcumin's anticancer properties via cell survival assays and gene expression analyses. Methods: Cell survival assays were performed by the CTD2 Centre at the Broad Institute. 860 human cancer cell lines were seeded into 1536-well plates, and 24 hours after plating, either DMSO control or curcumin was added to the wells at 16 different concentrations by serial dilution. 72 hours later, cellular ATP levels were measured with CellTiter-Glo as an indication of cell survival. For gene expression analysis, the L1000 assay from the Broad Institute was used. 9 core cell lines were treated with 10 μM of curcumin in 384-well plates. After 6 and 24 hours of incubation, a gene expression signature was identified with the Affymetrix GeneChip HG-U133 Plus 2.0 Array. This signature was compared against signatures from other small molecule and genetic perturbations contained in the CMap database. Afterwards, connectivity scores (incorporating an enrichment score, nominal p-value, and false discovery rate) were used to rank the L1000 signatures by similarity to the signature induced by curcumin. Results: Curcumin was most potent against SEM (IC50 = 1.00 μM; B-acute lymphoblastic leukemia), RPMI-8226 (IC50= 1.62 μM; myeloma), and SCC-4 (IC50 = 1.81 μM; squamous cell carcinoma) cell lines. Lymphoid and peripheral nervous system cancers were generally the most sensitive to curcumin, whereas prostate cancers were the least sensitive. Curcumin-induced gene expression changes resembled GPR87 and PRKRA knockdowns, which are associated with reductions in cancer cell survival, chemoresistance, and proliferation in various cancer cell lines. However, these transcriptomic changes also resembled CERS2 downregulation, which is associated with increased cell migration. In vitro, curcumin treatment mimicked 2',5'-dideoxyadenosine, BMS-299897, and eudesmic acid administration. Conclusion: Curcumin induces changes in cell survival and gene expression that support its anticancer properties in a variety of cancer cell lines. However, separating these effects from CERS2 downregulation may be an important component of future translational research for curcumin and its analogs. Citation Format: Adin Aggarwal, Jacqueline H. Law, Clement Lo, Kenneth W. Yip. A systems biology approach uncovers the anticancer mechanisms of curcumin [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular s); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl) nr 645.

Curcumin: An Insight into Molecular Pathways Involved in Anticancer Activity

Curcumin and cancer biology: Focusing regulatory effects in different signalling pathways

Curcuminoids as Cell Signaling Pathway Modulators: A Potential Strategy for Cancer Prevention

Role of the Dietary Phytochemical Curcumin in Targeting Cancer Cell Signalling Pathways

Curcumin: reclaiming the lost ground against cancer resistance

Curcumin: The story so far

Cellular and molecular mechanisms of curcumin in prevention and treatment of disease

Curcumin and Cancer

Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression

Curcumin’s Potential as A Drug Delivery Method and Anticancer Treatment

Non-Curcuminoids from Turmeric and Their Potential in Cancer Therapy and Anticancer Drug Delivery Formulations

Ancient Drug Curcumin Impedes 26S Proteasome Activity by Direct Inhibition of Dual-Specificity Tyrosine-Regulated Kinase 2

Curcumin and tumor immune-editing: resurrecting the immune system

Curcumin and Related Compounds in Cancer Cells: New Avenues for Old Molecules

Abstract 645: A systems biology approach uncovers the anticancer mechanisms of curcumin

Chemotherapeutic efficacy of curcumin and resveratrol against cancer: Chemoprevention, chemoprotection, drug synergism and clinical pharmacokinetics

Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells

A Review of Curcumin and Its Derivatives as Anticancer Agents

The Role of Curcumin in Cancer: A Focus on the PI3K/Akt Pathway

An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management

Curcumin and its formulations: potential anti-cancer agents.